Top compounds associated with response to ANAPC15


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA Imatinib GDSC1000 pan-cancer AAC -0.016 0.8
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.0087 0.8
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.022 0.8
mRNA B02 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA ZG-10 GDSC1000 pan-cancer AAC -0.013 0.8
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.021 0.8
mRNA SB52334 GDSC1000 pan-cancer AAC -0.0092 0.8
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.0084 0.8
Download CSV